Treace Announces First Surgical Cases with the Tailorplasty™ MIS Tailor’s Bunion Correction System

(NASDAQ:TMCI) Treace Medical Concepts, Inc. announced the successful completion of the first cases utilizing its Tailorplasty™ MIS Tailor’s Bunion Correction System. The Tailorplasty™ procedure extends Treace's instrumented bunion correction platform to tailor's bunions, also known as bunionettes, which are painful deformities of the fifth metatarsal estimated to affect approximately 5-10% of the adult population. The system provides instrument-guided surgical correction of the bunionette deformity through a minimally invasive surgery (MIS) with an incision of less than 1cm and features a unique fixation implant that inserts over a guidewire for controlled, reproducible correction and stability during healing. Jonathan Kaplan, MD, a surgeon design team member for the Tailorplasty™ System, stated that tailor's bunions are commonly treated in his practice and that the system was developed to help surgeons achieve quick, controlled, and accurate correction through a MIS approach. John T. Treace, CEO and Chairman of Treace, commented that the initial Tailorplasty™ cases represent an important step in expanding the company's 3D bunion correction portfolio. Treace estimates that tailor's bunions affect an estimated 5-10% of adults in the US and that the Tailorplasty™ System represents an underserved $300 million total addressable market (TAM) expansion opportunity for the business. The company states that Tailorplasty™ delivers a new solution aimed to transform a challenging freehand surgery into one with instrumented control and reproducibility. Commercialization of the Tailorplasty™ System is anticipated in the first quarter of 2027. Bunions are described as complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 67 million Americans, with Treace estimating 1.1 million annual surgical candidates. Treace has pioneered and patented the Lapiplasty® 3D Bunion Correction® System, which is designed to surgically correct all three planes of the bunion deformity and secure the unstable joint. The company also offers the Adductoplasty® Midfoot Correction System, the Nanoplasty® 3D Minimally Invasive Bunion Correction System, the Percuplasty® Percutaneous 3D Bunion Correction System, and the SpeedMTP® 1st MTP Fusion System. Treace is expanding its SpeedPlate® rapid compression implant platform to new applications and provides IntelliGuide® patient-specific, pre-op planning and cut guide technology, as well as SuperBite™ Fully-Threaded Compression Screws for use in fusions and osteotomies throughout the foot.